Autolus Therapeutics (AUTL) Non Operating Income (2017 - 2025)
Historic Non Operating Income for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$7.0 million.
- Autolus Therapeutics' Non Operating Income rose 5093.69% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.8 million, marking a year-over-year increase of 20467.94%. This contributed to the annual value of $22.3 million for FY2024, which is 17766.98% up from last year.
- Autolus Therapeutics' Non Operating Income amounted to -$7.0 million in Q3 2025, which was up 5093.69% from $13.7 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Non Operating Income registered a high of $979.0 million during Q3 2021, and its lowest value of -$23.9 million during Q4 2023.
- Its 5-year average for Non Operating Income is $51.1 million, with a median of -$1.1 million in 2023.
- In the last 5 years, Autolus Therapeutics' Non Operating Income surged by 3970355.99% in 2021 and then tumbled by 188273.66% in 2024.
- Over the past 5 years, Autolus Therapeutics' Non Operating Income (Quarter) stood at -$1.0 million in 2021, then soared by 505.09% to $4.2 million in 2022, then plummeted by 666.79% to -$23.9 million in 2023, then surged by 307.82% to $49.7 million in 2024, then crashed by 114.01% to -$7.0 million in 2025.
- Its last three reported values are -$7.0 million in Q3 2025, $13.7 million for Q2 2025, and -$2.7 million during Q1 2025.